Study protocol TransTAM: Transdiagnostic research into emotional disorders and cognitive-behavioral therapy of the adaptive mind

Background Emotional disorders such as depression and anxiety disorders share substantial similarities in their etiology and treatment. In recent decades, these commonalities have been increasingly recognized in classification systems and treatment programs crossing diagnostic boundaries. Methods To...

Full description

Saved in:
Bibliographic Details
Published in:BMC Psychiatry 2024, Vol.24 (1)
Main Authors: Hermann, Andrea, Benke, Christoph, Blecker, Carlo R, de Haas, Benjamin, He, Yifei, Hofmann, Stefan G, Iffland, Jona R, Jengert-Stahl, Johanna, Kircher, Tilo, Leinweber, Katrin, Linka, Marcel, Mulert, Christoph, Neudert, Marie K, Noll, Ann-Kathrin, Melzig, Christiane A, Rief, Winfried, Rothkopf, Constantin, Schäfer, Axel, Schmitter, Christina V, Schuster, Verena, Stark, Rudolf, Straube, Benjamin, Zimmer, Raphaela I, Kirchner, Lukas
Format: Report
Language:English
Subjects:
Analysis
Biological markers
Care and treatment
Cognitive therapy
Diagnosis
Mental illness
Patient outcomes
Psychology, Pathological
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Emotional disorders such as depression and anxiety disorders share substantial similarities in their etiology and treatment. In recent decades, these commonalities have been increasingly recognized in classification systems and treatment programs crossing diagnostic boundaries. Methods To examine the prospective effects of different transdiagnostic markers on relevant treatment outcomes, we plan to track a minimum of N = 200 patients with emotional disorders during their routine course of cognitive behavioral therapy at two German outpatient clinics. We will collect a wide range of transdiagnostic markers, ranging from basic perceptual processes and self-report measures to complex behavioral and neurobiological indicators, before entering therapy. Symptoms and psychopathological processes will be recorded before entering therapy, between the 20th and 24th therapy session, and at the end of therapy. Discussion Our results could help to identify transdiagnostic markers with high predictive power, but also provide deeper insights into which patient groups with which symptom clusters are less likely to benefit from therapy, and for what reasons. Trial Registration The trial was preregistered at the German Clinical Trial Register (DRKS-ID: DRKS00031206; 2023-05-09). Keywords: Therapy response, Therapy outcome prediction, Naturalistic outpatient sample, Neurobiological markers, Transdiagnostic markers, Transdiagnostic symptom dimensions, Longitudinal study, Cognitive behavioral therapy
ISSN:1471-244X
1471-244X
DOI:10.1186/s12888-024-06108-0